These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16307437)

  • 1. Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-tooth disease type 1A.
    Massa R; Palumbo C; Cavallaro T; Panico MB; Bei R; Terracciano C; Rizzuto N; Bernardi G; Modesti A
    Muscle Nerve; 2006 Mar; 33(3):342-9. PubMed ID: 16307437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination.
    Sahenk Z
    Ann N Y Acad Sci; 1999 Sep; 883():415-26. PubMed ID: 10586265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. erbb3 and erbb2 are essential for schwann cell migration and myelination in zebrafish.
    Lyons DA; Pogoda HM; Voas MG; Woods IG; Diamond B; Nix R; Arana N; Jacobs J; Talbot WS
    Curr Biol; 2005 Mar; 15(6):513-24. PubMed ID: 15797019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
    Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
    Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral nerve extracellular matrix remodeling in Charcot-Marie-Tooth type I disease.
    Palumbo C; Massa R; Panico MB; Di Muzio A; Sinibaldi P; Bernardi G; Modesti A
    Acta Neuropathol; 2002 Sep; 104(3):287-96. PubMed ID: 12172915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease.
    Fornasari BE; Ronchi G; Pascal D; Visigalli D; Capodivento G; Nobbio L; Perroteau I; Schenone A; Geuna S; Gambarotta G
    Exp Biol Med (Maywood); 2018 Feb; 243(4):370-374. PubMed ID: 29350067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration.
    Carroll SL; Miller ML; Frohnert PW; Kim SS; Corbett JA
    J Neurosci; 1997 Mar; 17(5):1642-59. PubMed ID: 9030624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of neuregulin isoforms and erbB receptors in myelinating glial cells.
    Raabe TD; Deadwyler G; Varga JW; Devries GH
    Glia; 2004 Jan; 45(2):197-207. PubMed ID: 14730713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.
    Stonecypher MS; Byer SJ; Grizzle WE; Carroll SL
    Oncogene; 2005 Aug; 24(36):5589-605. PubMed ID: 15897877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of Human Tonsil-Derived Mesenchymal Stem Cells into Schwann-Like Cells Improves Neuromuscular Function in a Mouse Model of Charcot-Marie-Tooth Disease Type 1A.
    Park S; Jung N; Myung S; Choi Y; Chung KW; Choi BO; Jung SC
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30110925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.
    Atanasoski S; Scherer SS; Nave KA; Suter U
    J Neurosci Res; 2002 Feb; 67(4):443-9. PubMed ID: 11835311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmyelinating Schwann cell involvement with well-preserved unmyelinated axons in Charcot-Marie-Tooth disease type 1A.
    Koike H; Iijima M; Mori K; Yamamoto M; Hattori N; Katsuno M; Tanaka F; Watanabe H; Doyu M; Yoshikawa H; Sobue G
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1027-36. PubMed ID: 17984684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
    Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
    Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of the Charcot-Marie-Tooth associated MTMR2 gene decreases proliferation and enhances cell death in primary cultures of Schwann cells.
    Chojnowski A; Ravisé N; Bachelin C; Depienne C; Ruberg M; Brugg B; Laporte J; Baron-Van Evercooren A; LeGuern E
    Neurobiol Dis; 2007 May; 26(2):323-31. PubMed ID: 17336078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oct6, a transcription factor controlling myelination, is a marker for active nerve regeneration in peripheral neuropathies.
    Kawasaki T; Oka N; Tachibana H; Akiguchi I; Shibasaki H
    Acta Neuropathol; 2003 Mar; 105(3):203-8. PubMed ID: 12557005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies.
    Fledrich R; Akkermann D; Schütza V; Abdelaal TA; Hermes D; Schäffner E; Soto-Bernardini MC; Götze T; Klink A; Kusch K; Krueger M; Kungl T; Frydrychowicz C; Möbius W; Brück W; Mueller WC; Bechmann I; Sereda MW; Schwab MH; Nave KA; Stassart RM
    Nat Commun; 2019 Apr; 10(1):1467. PubMed ID: 30931926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy.
    Ravera S; Nobbio L; Visigalli D; Bartolucci M; Calzia D; Fiorese F; Mancardi G; Schenone A; Morelli A; Panfoli I
    J Neurochem; 2013 Jul; 126(1):82-92. PubMed ID: 23578247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy.
    Nobbio L; Fiorese F; Vigo T; Cilli M; Gherardi G; Grandis M; Melcangi RC; Mancardi G; Abbruzzese M; Schenone A
    J Neuropathol Exp Neurol; 2009 May; 68(5):441-55. PubMed ID: 19525893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.